Showing results (321-330 of 333) with videos related to
Sort By:
Pageof 34
Cardiovascular and Interventional Radiology|July 26, 2005
Treatment of neuroendocrine cancer metastatic to the liver: the role of ablative techniquesT D Atwell, J W Charboneau, F G Que, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2001
Phase I trial of gemcitabine and CPT-11 given weekly for four weeks every six weeksS R Alberts, C Erlichman, J Sloan, et al.Gene Therapy|May 1, 1997
Phase I study of immunotherapy of hepatic metastases of colorectal carcinoma by direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7J Rubin, E Galanis, H C Pitot, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase III clinical trial of the combination of cisplatin, dacarbazine, and carmustine with or without tamoxifen in patients with advanced malignant melanomaE T Creagan, V J Suman, R J Dalton, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II studyS R Alberts, P M Townley, R M Goldberg, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1997
Phase II trial of irinotecan in patients with metastatic colorectal carcinomaH C Pitot, D B Wender, M J O'Connell, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2002
Gemcitabine and oxaliplatin for patients with advanced or metastatic pancreatic cancer: a North Central Cancer Treatment Group (NCCTG) phase I studyS R Alberts, P M Townley, R M Goldberg, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2000
Phase I and pharmacokinetic study of irinotecan and docetaxel in patients with advanced solid tumors: preliminary evidence of clinical activityA A Adjei, C E Klein, H Kastrissios, et al.Journal of the National Cancer Institute|October 28, 1998
Effects of the antiestrogens tamoxifen, toremifene, and ICI 182,780 on endometrial cancer growthR M O'Regan, A Cisneros, G M England, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1999
Phase I trial of dolastatin-10 (NSC 376128) in patients with advanced solid tumorsH C Pitot, E A McElroy, J M Reid, et al.Pageof 34